MassMutual Private Wealth & Trust’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
MassMutual Private Wealth & Trust's PHAT Position: Q3 2026 in Review
MassMutual Private Wealth & Trust sold out of Phathom Pharmaceuticals (PHAT) in Q3 2026, closing a stake of 427 shares — an estimated $4.63K sold.
MassMutual Private Wealth & Trust first reported a position in PHAT in Q3 2022 and held it in 6 quarters. The position peaked at $5.31K in Q4 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- MassMutual Private Wealth & Trust reported no remaining Phathom Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- MassMutual Private Wealth & Trust sold 427 Phathom Pharmaceuticals shares in Q3 2026, an estimated $4.63K.
- MassMutual Private Wealth & Trust first reported a position in Phathom Pharmaceuticals in Q3 2022 and held it in 6 quarters.
- MassMutual Private Wealth & Trust's Phathom Pharmaceuticals position peaked at $5.31K in Q4 2025.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.